Related Experiment Video
Updated: Dec 3, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
ARHGAP36 regulates proliferation and migration in papillary thyroid carcinoma cells
Ting Yan1, Wangwang Qiu1, Jianlu Song1
1Department of Thyroid, Parathyroid, Breast and Hernia Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, People's Republic of China.
Researchers identified ARHGAP36 as a potential biomarker for papillary thyroid carcinoma (PTC) recurrence and metastasis. This gene is highly expressed in malignant PTC cells and can be targeted for new therapies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Papillary thyroid carcinoma (PTC) recurrence and metastasis pose significant clinical challenges.
- Lack of specific diagnostic markers and therapeutic targets hinders effective management.
- Single-cell RNA sequencing (scRNA-seq) offers a high-resolution approach to identify cancer biomarkers.
Purpose of the Study:
- To investigate cell profiles in primary PTC, lymph node metastasis, and normal tissues using scRNA-seq.
- To identify specific gene expression differences between malignant and non-malignant cells.
- To evaluate ARHGAP36 as a potential diagnostic marker and therapeutic target for PTC recurrence and metastasis.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) of primary tumor, lymph node metastasis, and adjacent normal tissues from a PTC patient.
- Transcriptome profiling of 11,805 single cells.
- Confirmation of ARHGAP36 expression using immunostaining and qRT-PCR.
- Functional analysis of ARHGAP36 knockdown on PTC cell proliferation and migration via RNA sequencing.
Main Results:
- Malignant cells showed transcriptional overlap between primary and metastatic lesions.
- ARHGAP36 was highly expressed in primary and metastatic malignant PTC cells, but not in normal cells.
- ARHGAP36 expression was significantly higher in carcinoma tissues compared to normal tissues.
- ARHGAP36 knockdown inhibited PTC cell proliferation and migration in vitro, affecting associated signaling pathways.
Conclusions:
- ARHGAP36 is exclusively expressed in malignant cells of primary and metastatic PTC.
- ARHGAP36 regulates PTC cell proliferation and migration.
- ARHGAP36 represents a promising diagnostic marker and therapeutic target for papillary thyroid carcinoma.
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

